SC 57461A |
|||
A4408-5 | ApexBio | 5 mg | EUR 171 |
Description: SC-57461A is a selective inhibitor of human recombinant LTB4 with IC50 value of 49 nM [1].LTB4 (leukotriene B (4)) is a leukotriene and plays an important role in inflammation. |
Apexbio Reagents Laboratories manufactures the a81675 apexbio reagents distributed by Genprice. The A81675 Apexbio reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Apexbio Reagents. Other A81675 products are available in stock. Specificity: A81675 Category: Apexbio
Amyloid Precursor C-Terminal Peptide |
||
ApexBio | 1 mg | EUR 113 |
Description: Amyloid precursor c-terminal peptide (APP) (C86H118N20O27S) has the amino acid sequence Gly-Tyr-Glu-Asn-Pro-Thr-Tyr-Lys-Phe-Phe-Glu-Gln-Met-Gln-Asn. Although it has been implicated as a regulator of synapse formation, neural plasticity and iron export, the primary function of APP is not known. |
Amyloid Precursor C-Terminal Peptide |
||
ApexBio | 10 mg | EUR 369 |
Description: Amyloid precursor c-terminal peptide (APP) (C86H118N20O27S) has the amino acid sequence Gly-Tyr-Glu-Asn-Pro-Thr-Tyr-Lys-Phe-Phe-Glu-Gln-Met-Gln-Asn. Although it has been implicated as a regulator of synapse formation, neural plasticity and iron export, the primary function of APP is not known. |
Amyloid Precursor C-Terminal Peptide |
||
ApexBio | 25 mg | EUR 496 |
Description: Amyloid precursor c-terminal peptide (APP) (C86H118N20O27S) has the amino acid sequence Gly-Tyr-Glu-Asn-Pro-Thr-Tyr-Lys-Phe-Phe-Glu-Gln-Met-Gln-Asn. Although it has been implicated as a regulator of synapse formation, neural plasticity and iron export, the primary function of APP is not known. |
Amyloid Precursor C-Terminal Peptide |
||
ApexBio | 5 mg | EUR 241 |
Description: Amyloid precursor c-terminal peptide (APP) (C86H118N20O27S) has the amino acid sequence Gly-Tyr-Glu-Asn-Pro-Thr-Tyr-Lys-Phe-Phe-Glu-Gln-Met-Gln-Asn. Although it has been implicated as a regulator of synapse formation, neural plasticity and iron export, the primary function of APP is not known. |
Beta-Sheet Breaker Peptide iA?5 |
||
ApexBio | 10 mg | EUR 137 |
Description: Beta-Sheet Breaker Peptide iA?5 (C33H43N5O8), with the sequence H-Leu-Pro-Phe-Phe-Asp-OH, has been shown to inhibit amyloidogenesis in rat brain models. |
Beta-Sheet Breaker Peptide iA?5 |
||
ApexBio | 25 mg | EUR 171 |
Description: Beta-Sheet Breaker Peptide iA?5 (C33H43N5O8), with the sequence H-Leu-Pro-Phe-Phe-Asp-OH, has been shown to inhibit amyloidogenesis in rat brain models. |
Beta-Sheet Breaker Peptide iA?5 |
||
ApexBio | 5 mg | EUR 102 |
Description: Beta-Sheet Breaker Peptide iA?5 (C33H43N5O8), with the sequence H-Leu-Pro-Phe-Phe-Asp-OH, has been shown to inhibit amyloidogenesis in rat brain models. |
PETCM |
|||
A4420-50 | ApexBio | 50 mg | EUR 383 |
Description: PETCM is an activator of caspase-3 [1]. Caspase-3 is a member of the cysteine-aspartic acid protease family and interacts with caspase-8 and caspase-9. Sequential activation of caspases plays an important role in cell apoptosis. |
L 006235 |
|||
A4422-10 | ApexBio | 10 mg | EUR 421 |
Description: IC50: 0.25 nML-006235 is a potent and selective inhibitor of Cathepsin K.In vitro: After dilution of L-006235 to 0.05 nM, the cathepsin K enzyme activity was initially inhibited. |
L 006235 |
|||
A4422-50 | ApexBio | 50 mg | EUR 1617 |
Description: IC50: 0.25 nML-006235 is a potent and selective inhibitor of Cathepsin K.In vitro: After dilution of L-006235 to 0.05 nM, the cathepsin K enzyme activity was initially inhibited. |
SID 26681509 |
|||
A4424-10 | ApexBio | 10 mg | EUR 399 |
Description: IC50: 56 nMSID 26681509 is a potent and reversible human cathepsin L inhibitor.The cathepsins have been found to comprise a family of lysosomal protease enzymes whose primary functions, such as protein degradation, play a keyl role in normal cellular homeostasis. |
SID 26681509 |
|||
A4424-50 | ApexBio | 50 mg | EUR 1520 |
Description: IC50: 56 nMSID 26681509 is a potent and reversible human cathepsin L inhibitor.The cathepsins have been found to comprise a family of lysosomal protease enzymes whose primary functions, such as protein degradation, play a keyl role in normal cellular homeostasis. |
DPPI 1c hydrochloride |
|||
A4425-1 | ApexBio | 1 mg | EUR 226 |
Description: Inhibitor of dipeptidyl peptidase IV (DPP-IV) (IC50 = 104 nM) that displays selectivity over enzymes with DPP-like activity (IC50 > 30 ?M). Increases plasma GLP-1 levels and improves glucose tolerance in diabetic mice following oral glucose challenge. |
DPPI 1c hydrochloride |
|||
A4425-10 | ApexBio | 10 mg | EUR 431 |
Description: Inhibitor of dipeptidyl peptidase IV (DPP-IV) (IC50 = 104 nM) that displays selectivity over enzymes with DPP-like activity (IC50 > 30 ?M). Increases plasma GLP-1 levels and improves glucose tolerance in diabetic mice following oral glucose challenge. |
K 579 |
|||
A4426-10 | ApexBio | 10 mg | EUR 431 |
Description: Dipeptidyl peptidase IV inhibitor. Inhibits rat, canine, human and monkey enzymes with IC50 values of 3, 5, 8, and 8 nM respectively. Long-acting hypoglycemic agent; attenuates glucose excursion following glucose loading in Zucker fatty rats. |
K 579 |
|||
A4426-50 | ApexBio | 50 mg | EUR 1656 |
Description: Dipeptidyl peptidase IV inhibitor. Inhibits rat, canine, human and monkey enzymes with IC50 values of 3, 5, 8, and 8 nM respectively. Long-acting hypoglycemic agent; attenuates glucose excursion following glucose loading in Zucker fatty rats. |
NVP DPP 728 dihydrochloride |
|||
A4427-10 | ApexBio | 10 mg | EUR 273 |
Description: NVP DPP 728 dihydrochlorideDescription:Ki: Inhibit human DPP-IV amidolytic activity with a Ki of 11 nM [1]Inhibitors of dipeptidyl peptidase 4, also known as DPP-4 inhibitors or gliptins, are a class of oral hypoglycemics that can be used to treat diabetes mellitus type 2. |
NVP DPP 728 dihydrochloride |
|||
A4427-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 224 |
Description: NVP DPP 728 dihydrochlorideDescription:Ki: Inhibit human DPP-IV amidolytic activity with a Ki of 11 nM [1]Inhibitors of dipeptidyl peptidase 4, also known as DPP-4 inhibitors or gliptins, are a class of oral hypoglycemics that can be used to treat diabetes mellitus type 2. |
NVP DPP 728 dihydrochloride |
|||
A4427-50 | ApexBio | 50 mg | EUR 999 |
Description: NVP DPP 728 dihydrochlorideDescription:Ki: Inhibit human DPP-IV amidolytic activity with a Ki of 11 nM [1]Inhibitors of dipeptidyl peptidase 4, also known as DPP-4 inhibitors or gliptins, are a class of oral hypoglycemics that can be used to treat diabetes mellitus type 2. |
PK 44 phosphate |
|||
A4428-10 | ApexBio | 10 mg | EUR 545 |
Description: PK 44 phosphateDescription:IC50: 15.8 nm (DPP-IV)The protein encoded by the DPP4 gene is an antigenic enzyme expressed on the surface of most cell types and is associated with immune regulation, signal transduction and apoptosis. |
Vialinin A |
|||
A4429-1 | ApexBio | 1 mg | EUR 113 |
Description: Vialinin A is a potent inhibitor of ubiquitin-specific peptidases with IC50 values of 1.5, 5.9 and 22.3 ?M for ubiquitin-specific peptidase 4 (USP4), USP5/isopeptidase T (IsoT) and UCH-L1 deubiquitinating enzyme (DUB), respectively [1]. |
Vialinin A |
|||
A4429-10 | ApexBio | 10 mg | EUR 561 |
Description: Vialinin A is a potent inhibitor of ubiquitin-specific peptidases with IC50 values of 1.5, 5.9 and 22.3 ?M for ubiquitin-specific peptidase 4 (USP4), USP5/isopeptidase T (IsoT) and UCH-L1 deubiquitinating enzyme (DUB), respectively [1]. |
Vialinin A |
|||
A4429-25 | ApexBio | 25 mg | EUR 1170 |
Description: Vialinin A is a potent inhibitor of ubiquitin-specific peptidases with IC50 values of 1.5, 5.9 and 22.3 ?M for ubiquitin-specific peptidase 4 (USP4), USP5/isopeptidase T (IsoT) and UCH-L1 deubiquitinating enzyme (DUB), respectively [1]. |
Vialinin A |
|||
A4429-5 | ApexBio | 5 mg | EUR 338 |
Description: Vialinin A is a potent inhibitor of ubiquitin-specific peptidases with IC50 values of 1.5, 5.9 and 22.3 ?M for ubiquitin-specific peptidase 4 (USP4), USP5/isopeptidase T (IsoT) and UCH-L1 deubiquitinating enzyme (DUB), respectively [1]. |